Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H18N2 |
| Molecular Weight | 214.3061 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC[C@]1([H])C3=CC=CC4=C3N2CCNC4
InChI
InChIKey=XOSKJKGKWRIMGV-DGCLKSJQSA-N
InChI=1S/C14H18N2/c1-3-10-9-15-7-8-16-13-6-2-4-11(13)12(5-1)14(10)16/h1,3,5,11,13,15H,2,4,6-9H2/t11-,13-/m1/s1
| Molecular Formula | C14H18N2 |
| Molecular Weight | 214.3061 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:49:55 GMT 2023
by
admin
on
Sat Dec 16 18:49:55 GMT 2023
|
| Record UNII |
MN9LW8268N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10130594
Created by
admin on Sat Dec 16 18:49:55 GMT 2023 , Edited by admin on Sat Dec 16 18:49:55 GMT 2023
|
PRIMARY | |||
|
DTXSID40436021
Created by
admin on Sat Dec 16 18:49:55 GMT 2023 , Edited by admin on Sat Dec 16 18:49:55 GMT 2023
|
PRIMARY | |||
|
MN9LW8268N
Created by
admin on Sat Dec 16 18:49:55 GMT 2023 , Edited by admin on Sat Dec 16 18:49:55 GMT 2023
|
PRIMARY | |||
|
WAY-163909
Created by
admin on Sat Dec 16 18:49:55 GMT 2023 , Edited by admin on Sat Dec 16 18:49:55 GMT 2023
|
PRIMARY | |||
|
428868-32-0
Created by
admin on Sat Dec 16 18:49:55 GMT 2023 , Edited by admin on Sat Dec 16 18:49:55 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
20-and 46-fold binding selectivity over 5-HT2A and 5-HT2Breceptors,respectively.
Ki
|
||
|
OFF TARGET->WEAK AGONIST |
Emax,40%
|
||
|
TARGET -> AGONIST |
Emax, ~90%
EC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
